Fitzgerald Thomas Ainsider trades

In SEC Form 4 filings, Fitzgerald Thomas A is listed as Chief Financial Officer of Transcode Therapeutics, Inc. (RNAZ). Fitzgerald Thomas A reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 11.

Companies and roles

Company	Role	Transactions	Last filed
RNAZTranscode Therapeutics, Inc.	Chief Financial Officer	1	Sep 11

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-11

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
RNAZTranscode Therapeutics, Inc.	Sep 9	Sep 11	A · derivative	185,000	$1.78	$329,300	185,000	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.